MPO and neoplasm: S100A8/A9 also activates myeloperoxidase (MPO) activation, releases and accumulates oxidized lipids, and upregulates the fibroblast growth factor receptor (FGFR) pathway in tumor cells, causing tumor cells to be released from dormancy, reactivated, and form new tumor foci.